In addition, secondary resistance to immune checkpoint blockade in human and mouse HCC is also driven by peroxisome proliferator-activated receptor gamma (PPARγ)-induced MDSC expansion [49]. This evidence concerns the gene PPARG and hepatocellular carcinoma.